Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium

An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised internat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of tropical medicine and hygiene 2015-11, Vol.93 (5), p.1110-1116
Hauptverfasser: Schwartz, Brian S, Rosen, Jessica, Han, Pauline V, Hynes, Noreen A, Hagmann, Stefan H, Rao, Sowmya R, Jentes, Emily S, Ryan, Edward T, LaRocque, Regina C, The Global TravEpiNet Consortium
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1116
container_issue 5
container_start_page 1110
container_title The American journal of tropical medicine and hygiene
container_volume 93
creator Schwartz, Brian S
Rosen, Jessica
Han, Pauline V
Hynes, Noreen A
Hagmann, Stefan H
Rao, Sowmya R
Jentes, Emily S
Ryan, Edward T
LaRocque, Regina C
The Global TravEpiNet Consortium
description An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful.
doi_str_mv 10.4269/ajtmh.15-0185
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4703284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1765943276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-270bcc99340bb55aadc51c0599250fb79a59d44e9f8c2f1b2a6a8df7da20a043</originalsourceid><addsrcrecordid>eNqNkcFu1DAQhi1ERZeWI1fkIweytR07XnNAQqG0lSpA6nK2Jo7TuEriYDuVeA5eGG93W5UbJ8uez59m5kfoLSVrzip1Bndp7NdUFIRuxAu0olxWBa24eIlWhBBWqKqUx-h1jHckI4zSV-iYVSXhirEV-nM1jsvkjR_n4EcXbYu3Ae7tYEP8iL_Y0d8GmHtncN1DAJNscDE5Ez8cuMzk-wTJ-Sk_wtTiH8Gmfe3SwpB6XEOwuMt-nHqLf65v1vhi8A0MD47z2X2zCdf5vw_JLeMpOupgiPbN4TxB26_n2_qyuP5-cVV_vi4MZyQVTJLGGKVKTppGCIDWCGqIUIoJ0jVSgVAt51Z1G8M62jCoYNN2sgVGgPDyBH3aa-elGW1r7JS7HvQc3Ajht_bg9L-VyfX61t9rLknJNjvB-4Mg-F9LXoPOCzR2GGCyfomaykooXjJZ_QdaUqkI5ztrsUdN8DEG2z11RIneRa4fItdU6F3kmX_3fIwn-jHj8i_BUavC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1731790444</pqid></control><display><type>article</type><title>Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Schwartz, Brian S ; Rosen, Jessica ; Han, Pauline V ; Hynes, Noreen A ; Hagmann, Stefan H ; Rao, Sowmya R ; Jentes, Emily S ; Ryan, Edward T ; LaRocque, Regina C ; The Global TravEpiNet Consortium</creator><creatorcontrib>Schwartz, Brian S ; Rosen, Jessica ; Han, Pauline V ; Hynes, Noreen A ; Hagmann, Stefan H ; Rao, Sowmya R ; Jentes, Emily S ; Ryan, Edward T ; LaRocque, Regina C ; The Global TravEpiNet Consortium</creatorcontrib><description>An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful.</description><identifier>ISSN: 0002-9637</identifier><identifier>EISSN: 1476-1645</identifier><identifier>DOI: 10.4269/ajtmh.15-0185</identifier><identifier>PMID: 26304922</identifier><language>eng</language><publisher>United States: The American Society of Tropical Medicine and Hygiene</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Communicable Disease Control - methods ; Counseling ; Delivery of Health Care ; Demography ; Female ; Humans ; Immunocompromised Host - immunology ; Immunosuppressive Agents - therapeutic use ; Infant ; Male ; Middle Aged ; Travel ; United States ; Young Adult</subject><ispartof>The American journal of tropical medicine and hygiene, 2015-11, Vol.93 (5), p.1110-1116</ispartof><rights>The American Society of Tropical Medicine and Hygiene.</rights><rights>The American Society of Tropical Medicine and Hygiene 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-270bcc99340bb55aadc51c0599250fb79a59d44e9f8c2f1b2a6a8df7da20a043</citedby><cites>FETCH-LOGICAL-c420t-270bcc99340bb55aadc51c0599250fb79a59d44e9f8c2f1b2a6a8df7da20a043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703284/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703284/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26304922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwartz, Brian S</creatorcontrib><creatorcontrib>Rosen, Jessica</creatorcontrib><creatorcontrib>Han, Pauline V</creatorcontrib><creatorcontrib>Hynes, Noreen A</creatorcontrib><creatorcontrib>Hagmann, Stefan H</creatorcontrib><creatorcontrib>Rao, Sowmya R</creatorcontrib><creatorcontrib>Jentes, Emily S</creatorcontrib><creatorcontrib>Ryan, Edward T</creatorcontrib><creatorcontrib>LaRocque, Regina C</creatorcontrib><creatorcontrib>The Global TravEpiNet Consortium</creatorcontrib><title>Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium</title><title>The American journal of tropical medicine and hygiene</title><addtitle>Am J Trop Med Hyg</addtitle><description>An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Communicable Disease Control - methods</subject><subject>Counseling</subject><subject>Delivery of Health Care</subject><subject>Demography</subject><subject>Female</subject><subject>Humans</subject><subject>Immunocompromised Host - immunology</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infant</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Travel</subject><subject>United States</subject><subject>Young Adult</subject><issn>0002-9637</issn><issn>1476-1645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1DAQhi1ERZeWI1fkIweytR07XnNAQqG0lSpA6nK2Jo7TuEriYDuVeA5eGG93W5UbJ8uez59m5kfoLSVrzip1Bndp7NdUFIRuxAu0olxWBa24eIlWhBBWqKqUx-h1jHckI4zSV-iYVSXhirEV-nM1jsvkjR_n4EcXbYu3Ae7tYEP8iL_Y0d8GmHtncN1DAJNscDE5Ez8cuMzk-wTJ-Sk_wtTiH8Gmfe3SwpB6XEOwuMt-nHqLf65v1vhi8A0MD47z2X2zCdf5vw_JLeMpOupgiPbN4TxB26_n2_qyuP5-cVV_vi4MZyQVTJLGGKVKTppGCIDWCGqIUIoJ0jVSgVAt51Z1G8M62jCoYNN2sgVGgPDyBH3aa-elGW1r7JS7HvQc3Ajht_bg9L-VyfX61t9rLknJNjvB-4Mg-F9LXoPOCzR2GGCyfomaykooXjJZ_QdaUqkI5ztrsUdN8DEG2z11RIneRa4fItdU6F3kmX_3fIwn-jHj8i_BUavC</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Schwartz, Brian S</creator><creator>Rosen, Jessica</creator><creator>Han, Pauline V</creator><creator>Hynes, Noreen A</creator><creator>Hagmann, Stefan H</creator><creator>Rao, Sowmya R</creator><creator>Jentes, Emily S</creator><creator>Ryan, Edward T</creator><creator>LaRocque, Regina C</creator><creator>The Global TravEpiNet Consortium</creator><general>The American Society of Tropical Medicine and Hygiene</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T2</scope><scope>7U2</scope><scope>C1K</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope><scope>M7N</scope><scope>5PM</scope></search><sort><creationdate>20151101</creationdate><title>Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium</title><author>Schwartz, Brian S ; Rosen, Jessica ; Han, Pauline V ; Hynes, Noreen A ; Hagmann, Stefan H ; Rao, Sowmya R ; Jentes, Emily S ; Ryan, Edward T ; LaRocque, Regina C ; The Global TravEpiNet Consortium</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-270bcc99340bb55aadc51c0599250fb79a59d44e9f8c2f1b2a6a8df7da20a043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Communicable Disease Control - methods</topic><topic>Counseling</topic><topic>Delivery of Health Care</topic><topic>Demography</topic><topic>Female</topic><topic>Humans</topic><topic>Immunocompromised Host - immunology</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infant</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Travel</topic><topic>United States</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartz, Brian S</creatorcontrib><creatorcontrib>Rosen, Jessica</creatorcontrib><creatorcontrib>Han, Pauline V</creatorcontrib><creatorcontrib>Hynes, Noreen A</creatorcontrib><creatorcontrib>Hagmann, Stefan H</creatorcontrib><creatorcontrib>Rao, Sowmya R</creatorcontrib><creatorcontrib>Jentes, Emily S</creatorcontrib><creatorcontrib>Ryan, Edward T</creatorcontrib><creatorcontrib>LaRocque, Regina C</creatorcontrib><creatorcontrib>The Global TravEpiNet Consortium</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of tropical medicine and hygiene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartz, Brian S</au><au>Rosen, Jessica</au><au>Han, Pauline V</au><au>Hynes, Noreen A</au><au>Hagmann, Stefan H</au><au>Rao, Sowmya R</au><au>Jentes, Emily S</au><au>Ryan, Edward T</au><au>LaRocque, Regina C</au><au>The Global TravEpiNet Consortium</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium</atitle><jtitle>The American journal of tropical medicine and hygiene</jtitle><addtitle>Am J Trop Med Hyg</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>93</volume><issue>5</issue><spage>1110</spage><epage>1116</epage><pages>1110-1116</pages><issn>0002-9637</issn><eissn>1476-1645</eissn><abstract>An increasing number of immunocompromised individuals are pursuing international travel, and a better understanding of their international travel patterns and pretravel health care is needed. We evaluated the clinical features, itineraries, and pretravel health care of 486 immunocompromised international travelers seen at Global TravEpiNet sites from January 2009 to June 2012. We used bivariate analyses and logistic regressions using random intercept models to compare demographic and travel characteristics, vaccines administered, and medications prescribed for immunocompromised travelers versus 30,702 immunocompetent travelers. Immunocompromised travelers pursued itineraries that were largely similar to those of immunocompetent travelers, with nearly one-third of such travelers visiting countries with low human development indices. Biological agents, including tumor necrosis factor blockers, were commonly used immunosuppressive medications among immunocompromised travelers. A strong collaboration between travel-medicine specialists, primary care doctors, and specialist physicians is needed to prepare immunocompromised people for international travel. Incorporating routine questioning and planning regarding travel into the primary care visits of immunocompromised people may be useful.</abstract><cop>United States</cop><pub>The American Society of Tropical Medicine and Hygiene</pub><pmid>26304922</pmid><doi>10.4269/ajtmh.15-0185</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9637
ispartof The American journal of tropical medicine and hygiene, 2015-11, Vol.93 (5), p.1110-1116
issn 0002-9637
1476-1645
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4703284
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Communicable Disease Control - methods
Counseling
Delivery of Health Care
Demography
Female
Humans
Immunocompromised Host - immunology
Immunosuppressive Agents - therapeutic use
Infant
Male
Middle Aged
Travel
United States
Young Adult
title Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T14%3A20%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunocompromised%20Travelers:%20Demographic%20Characteristics,%20Travel%20Destinations,%20and%20Pretravel%20Health%20Care%20from%20the%20U.S.%20Global%20TravEpiNet%20Consortium&rft.jtitle=The%20American%20journal%20of%20tropical%20medicine%20and%20hygiene&rft.au=Schwartz,%20Brian%20S&rft.date=2015-11-01&rft.volume=93&rft.issue=5&rft.spage=1110&rft.epage=1116&rft.pages=1110-1116&rft.issn=0002-9637&rft.eissn=1476-1645&rft_id=info:doi/10.4269/ajtmh.15-0185&rft_dat=%3Cproquest_pubme%3E1765943276%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1731790444&rft_id=info:pmid/26304922&rfr_iscdi=true